Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.

Coronavirus Covid-19 omicron mutation. Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer ...

The two parties initially entered into a COVID vaccine supply deal in October 2020. The U.K. originally agreed to purchase 60 million doses of the company’s protein-based adjuvanted shot NVX ...

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...

Penn expecting $467M windfall from COVID-19 vaccine royalty dispute. At issue was how much the manufacturer could carve out to third parties before paying the university its stake of the profits in ...

The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair settled a lawsuit out of court in late December 2024.